Drug Type Small molecule drug |
Synonyms Docebenone (USAN/INN), A 61589, A-61589 + [2] |
Target |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H26O3 |
InChIKeyWDEABJKSGGRCQA-UHFFFAOYSA-N |
CAS Registry80809-81-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03882 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | US | - | - |
Asthma | Phase 2 | JP | - | |
Asthma | Phase 2 | CA | - | - |
Asthma | Phase 2 | PR | - | - |
Rhinitis, Allergic | Phase 2 | US | - | - |
Rhinitis, Allergic | Phase 2 | JP | - | |
Rhinitis, Allergic | Phase 2 | CA | - | - |
Rhinitis, Allergic | Phase 2 | PR | - | - |
Neoplasms | Preclinical | SE | - | - |
Stomach Diseases | Preclinical | JP | - |